Skip to main content

Open Access Bioresorbable Vascular Scaffold in the Midportion of the Left Anterior Descending Artery for Cardiac Allograft Vasculopathy in a Cardiac Transplant Patient

Download Article:
(PDF 1,166.8 kb)
In an era when cardiac transplant patients are surviving more immediate issues of rejection and infection, the prevalence of more chronic issues such as cardiac allograft vasculopathy (CAV) is rising. This case describes a man 20 years after cardiac transplant with his first presentation of CAV. Acute myocardial infarction was diagnosed on the basis of symptoms and biochemical markers and on coronary angiography, and he was found to have a critical stenosis of the midportion of the left anterior descending artery. It was elected to treat this percutaneously with a fully bioresorbable vascular scaffold (BVS) because of the diffuse nature of the disease process. This was successfully performed with optical coherence tomography guidance. The use of BVS in CAV has not been well studied. This is one of few case reports describing the use of BVS in CAV.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Affiliations: Fiona Stanley Hospital

Appeared or available online: 09 November 2017

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more